1328 GMT - BASF's 2025 outlook is similar to last year and reflects low upstream margins, UBS analysts say in a note. Excluding the start-up costs for its China site, the midpoint of its Ebitda guidance would mean a 10% or more on-year increase, they say. The German chemical giant estimates double-digit Ebitda growth for its Surface Technology segment in 2025, which is surprising given its high exposure to a weakened automotive sector, the analysts add. Its 4Q results showed a weak performance of its core segments, significantly below market expectations except for its Nutrition & Care business, they say. Shares are up 0.9% at 49.21 euros. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
February 28, 2025 08:28 ET (13:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。